Showing 2021-2030 of 3569 results for "".
The Role for Rinvoq in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/the-role-for-rinvoq-in-ad-care/23663/One of the first oral JAK inhibitors approved in dermatology expands options for moderate to severe AD.A First Look at Rotational Fractional Resection
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-first-look-at-rotational-fractional-resection/20383/A new technology offers a fresh approach to treatment of submental contouring.Point/Counterpoint: Is There a Role for Permanent Fillers?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pointcounterpoint-is-there-a-role-for-permanent-fillers/20916/Currents: Calming the Inflammation of Acne and Rosacea
https://practicaldermatology.com/topics/acne-rosacea/currents-calming-the-inflammation-of-acne-and-rosacea/23729/Special Report: Dermatology Industry Responds to Inequities in Care
https://practicaldermatology.com/topics/skin-of-color/special-report-dermatology-industry-responds-to-inequities-in-care/23765/Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.New Drugs in Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-drugs-in-psoriasis/20933/The last two years have seen a number of new drugs approved to treat psoriasis—from targeted biologics to new topicals.Currents: Year In Focus
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents-year-in-focus/23167/To Sell or Not To Sell: Strategic Options and Realizing Value
https://practicaldermatology.com/topics/practice-management/to-sell-or-not-to-sell-strategic-options-and-realizing-value/20418/Is this the right time to make a change? Here's what you need to know.Get Ready: The Biosimilars Are Here
https://practicaldermatology.com/topics/psoriasis/get-ready-the-biosimilars-are-here/20662/Recent developments mean that biosimilars are finally hitting the US market.